search
Back to results

Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients

Primary Purpose

COPD, Chronic Obstructive Pulmonary Disease

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
AIR-AD
Sponsored by
Right-Air
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for COPD

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1. Moderate to severe COPD (by ATS criteria)

  1. FEV1/FVC <0.70
  2. FEV1 < 60% Predicted

Exclusion Criteria:

  1. Physical limitation that prevents walking for 6 minutes (e.g. lower extremity amputation, arthritis limiting function, significant angina, etc…)
  2. Lung pathology not explained by COPD, which may limit functional capacity (e.g. pulmonary fibrosis, malignancy, history of lung reduction surgery, etc…)
  3. Pregnancy
  4. Age <18

Sites / Locations

  • John Hansen-FlaschenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Part 1: Feasibility

Part 2: Crossover

Arm Description

Patients will perform 6-minute walk test with AIR-AD to allow for observation and real-time feedback.

Crossover design where investigator will compare wearing of AIR-AD during exercise to compare distance walked with and without it.

Outcomes

Primary Outcome Measures

Assess distance travelled during 6-minute walk tests performed with and without device.
Distances travelled during two six minute walk tests will be measured. Investigator will compare distance travelled with use of the device to the distance travelled without the use of the device.

Secondary Outcome Measures

Assess for patient improvement in shortness of breath scores
This will be be measured via survey tool Borg Scale of Dyspnea (0 - no dyspnea, through 10 - maximal dyspnea). Patient scores will be measured during exercise testing with and without the device. Improvement will be considered a lower score on the Borg Scale.

Full Information

First Posted
April 16, 2018
Last Updated
May 8, 2018
Sponsor
Right-Air
Collaborators
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT03531489
Brief Title
Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients
Official Title
Pilot, Single Center Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Unknown status
Study Start Date
April 26, 2018 (Actual)
Primary Completion Date
December 30, 2018 (Anticipated)
Study Completion Date
December 30, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Right-Air
Collaborators
University of Pennsylvania

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is a two-part small scale, open-label, pilot study to evaluate feasibility and proof-of-concept for a respiratory assist medical device. The study population will consist of severe Chronic Obstructive Pulmonary Disease (COPD) subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COPD, Chronic Obstructive Pulmonary Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Part 1: Feasibility
Arm Type
Experimental
Arm Description
Patients will perform 6-minute walk test with AIR-AD to allow for observation and real-time feedback.
Arm Title
Part 2: Crossover
Arm Type
Experimental
Arm Description
Crossover design where investigator will compare wearing of AIR-AD during exercise to compare distance walked with and without it.
Intervention Type
Device
Intervention Name(s)
AIR-AD
Intervention Description
Non-significant risk medical device as decided by institutional review board
Primary Outcome Measure Information:
Title
Assess distance travelled during 6-minute walk tests performed with and without device.
Description
Distances travelled during two six minute walk tests will be measured. Investigator will compare distance travelled with use of the device to the distance travelled without the use of the device.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Assess for patient improvement in shortness of breath scores
Description
This will be be measured via survey tool Borg Scale of Dyspnea (0 - no dyspnea, through 10 - maximal dyspnea). Patient scores will be measured during exercise testing with and without the device. Improvement will be considered a lower score on the Borg Scale.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1. Moderate to severe COPD (by ATS criteria) FEV1/FVC <0.70 FEV1 < 60% Predicted Exclusion Criteria: Physical limitation that prevents walking for 6 minutes (e.g. lower extremity amputation, arthritis limiting function, significant angina, etc…) Lung pathology not explained by COPD, which may limit functional capacity (e.g. pulmonary fibrosis, malignancy, history of lung reduction surgery, etc…) Pregnancy Age <18
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Escobar
Phone
215-349-5023
Email
escobarm@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Perry Dubin, MD/MPH
Phone
6105172053
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Hansen-Flaschen, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
John Hansen-Flaschen
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Escobar
Phone
215-349-5023
Email
escobarm@pennmedicine.upenn.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Study of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease Patients

We'll reach out to this number within 24 hrs